NCT00127907View on ClinicalTrials.gov

Vasopressin and Epinephrine Versus Epinephrine Alone in Cardiac Arrest

PHASE4CompletedINTERVENTIONAL
Enrollment

2,416

Participants

Timeline

Start Date

May 31, 2004

Conditions
Cardiac Arrest
Interventions
DRUG

epinephrine (1 mg/1 mL)

DRUG

arginine-vasopressin (40 UI/2 mL)

Trial Locations (1)

69495

Centre Hospitalier Lyon Sud, Pierre-Bénite

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT00127907 - Vasopressin and Epinephrine Versus Epinephrine Alone in Cardiac Arrest | Biotech Hunter | Biotech Hunter